Scientists at Memorial Sloan Kettering Cancer Center (MSK) and their colleagues are shedding new light on a tumor's earliest ...
As the body ages, cells naturally accumulate dozens of genetic mutations each year. New research from Boston Children's Hospital, published in Cell, finds that the brain's resident immune cells, ...
Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna ...
New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...
Some 17 million Americans are living with genetic mutations tied to an increased risk of getting cancer, Cleveland Clinic researchers warned Monday. And the more than 3,400 mutations identified – ...
Michele Carbone and Haining Yang, professors at University of Hawaiʻi Cancer Center, are recipients of the prestigious V ...
Breast cancer is one of the most common malignancies worldwide, and mutations in the PI3K/AKT/mTOR (PAM) signaling pathway ...
Rezetapopt demonstrated a 44.4% overall response rate and durable responses lasting over eight months in patients with ...
New research from Boston Children’s Hospital, published in Cell, finds that the brain’s resident immune cells, microglia, ...
Around 60,000 people are diagnosed with pancreatic cancer each year.
Results from two early-stage trials offer new hope for a cancer that kills around one in eight patients within five years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results